| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/14/2012 | US8115078 Pepper hybrid HNS 14450321 |
| 02/14/2012 | US8115077 Soybean cultivar 88211855 |
| 02/14/2012 | US8115071 Soybean variety A1016137 |
| 02/14/2012 | US8115070 Soybean variety A1016053 |
| 02/14/2012 | US8115069 Soybean variety A1016124 |
| 02/14/2012 | US8115068 Soybean variety A1016119 |
| 02/14/2012 | US8115067 Soybean cultivar 05KG030123 |
| 02/14/2012 | US8115066 Soybean variety 0384531 |
| 02/14/2012 | US8115065 Squash line YCN 130-1053T |
| 02/14/2012 | US8115064 Watermelon line WAS146-4197 |
| 02/14/2012 | US8115063 Bacillus thuringiensis gene with coleopteran activity |
| 02/14/2012 | US8115062 Transgenic plants expressing recombinant barley alanine aminotransferase |
| 02/14/2012 | US8115061 Plant transformation method |
| 02/14/2012 | US8115060 Means and methods of controlling plant seed germination |
| 02/14/2012 | US8115059 Gene expression modulation system for use in plants and method for modulating gene expression in plants |
| 02/14/2012 | US8115058 Rice promoters for regulation of plant expression |
| 02/14/2012 | US8115057 Root-specific phosphate transporter promoters |
| 02/14/2012 | US8115056 Root-specific phosphate transporter promoters |
| 02/14/2012 | US8115055 Down-regulation of gene expression using artificial microRNAs |
| 02/14/2012 | US8115054 Maize with enhanced tolerance to fungal pathogen |
| 02/14/2012 | US8115053 Plant protection |
| 02/14/2012 | US8115052 for increasing yield in plants, particularly seed plants and protecting against environmental stress (drought, cold); genetic engineering |
| 02/14/2012 | US8114984 RNAi modulation of Aha and therapeutic uses thereof |
| 02/14/2012 | US8114983 Compositions and use of EPAS1 inhibitors |
| 02/14/2012 | US8114981 Method and medicament for inhibiting the expression of a given gene |
| 02/14/2012 | US8114980 Transforming caenorhabditis and using as animal model for gene expression inhibition; RNA interference |
| 02/14/2012 | US8114977 Proteins derived from white spot syndrome virus and uses thereof |
| 02/14/2012 | US8114975 Screening and identifying compounds compounds that will modulate the interaction of protein tyrosine kinase substrates with their intracellular ligands, as well as between their intracellular ligands and other members of the signaling pathway. |
| 02/14/2012 | US8114974 Engineered microorganisms with enhanced fermentation activity |
| 02/14/2012 | US8114971 Nucleotide sequences coding gramnegative bacterial lipoprotein for use in prevention and treatment of microorganismal infection; genetic vaccine |
| 02/14/2012 | US8114965 Compositions of PSMA antibodies |
| 02/14/2012 | US8114960 Heterologous expression of Neisserial proteins |
| 02/14/2012 | US8114908 Production of peracids using an enzyme having perhydrolysis activity |
| 02/14/2012 | US8114851 Double stranded RNA packaged in liposome for use therapeutic tool in treatment of cell proliferative and viral disorders; Antisense oligonucleotide for use in prevention and treatment of viral and tumor disorders; gene expression inhibition; RNA interference |
| 02/14/2012 | US8114849 Retinal dystrophy-associated protein and uses thereof |
| 02/14/2012 | US8114839 Protease resistant modified erythropoietin polypeptides |
| 02/14/2012 | US8114838 Methods for protecting dopaminergic neurons from stress and promoting proliferation and differentiation of oligodendrocyte progenitors by NRG-2 |
| 02/14/2012 | US8114665 Promoters and usage thereof |
| 02/14/2012 | US8114655 EGVII endoglucanase and nucleic acids encoding the same |
| 02/14/2012 | US8114654 Site-specific incorporation of redox active amino acids into proteins |
| 02/14/2012 | US8114653 Thermostable Y-family polymerases and chimeras |
| 02/14/2012 | US8114651 Method for producing 4-hydroxy-L-isoleucine |
| 02/14/2012 | US8114650 Nucleic acid and its use effecting ciliate tetrahymena bifunctional dihydrofolate reductase-thymidylate synthase deficiency |
| 02/14/2012 | US8114649 L-cysteine producing microorganism and a method for producing L-cysteine |
| 02/14/2012 | US8114648 immunizing a subject with a sufficient amount of a translated polypeptide to produce antibody; containing a phenylalanine or tyrosine derivative analoges |
| 02/14/2012 | US8114643 Producing 3-hydroxypropionic acid from transgenic organisms such as plants or bacteria that express vicinal diol dehydratase, aldehyde dehydrogenase, acyl-CoA transferase, acyl-CoA synthetase, polyhydroxyalkanoate synthase, glycerol-3-phosphate dehydrogenase and/or glycerol-3-phosphatase |
| 02/14/2012 | US8114640 Macrocyclization of compounds from solid support using thioesterases |
| 02/14/2012 | US8114638 Arabinitol dehydrogenase from Neurospora crassa |
| 02/14/2012 | US8114637 Packaging cells for recombinant adenovirus |
| 02/14/2012 | US8114634 Methods, systems and reagents for improved immunodetection |
| 02/14/2012 | US8114632 Method of producing biologically active polypeptide having insulinotropic activity |
| 02/14/2012 | US8114630 Modified interferon beta polypeptides and their uses |
| 02/14/2012 | US8114629 Site specific incorporation of keto amino acids into proteins |
| 02/14/2012 | US8114628 Expanding the eukaryotic genetic code |
| 02/14/2012 | US8114622 Methods for generation of reporter phages and immobilization of active bacteriophages on a polymer surface |
| 02/14/2012 | US8114603 collecting a blood sample from the subject; andmeasuring the levels of Triggering Receptor Expressed on Myeloid cells (TREM-1) splice variant protein in sample, a decrease in the levels of TREM-1 splice variant indicates an inflammatory response |
| 02/14/2012 | US8114601 Highly conserved genes and their use to generate probes and primers for detection of microorganisms |
| 02/14/2012 | US8114594 Crude biological derivatives competent for nucleic acid detection |
| 02/14/2012 | US8114589 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
| 02/14/2012 | US8114584 Antireflective coatings for high-resolution photolithographic synthesis of DNA array |
| 02/14/2012 | US8114581 Methods and compositions for detecting neoplastic cells |
| 02/14/2012 | US8114443 Phytase-expressing transgenic plants |
| 02/14/2012 | US8114418 Chimeric immunomodulatory compounds and methods of using the same—IV |
| 02/14/2012 | US8114417 Recombinant protective protein from Streptococcus pneumoniae |
| 02/14/2012 | US8114416 Modified oncolytic viruses |
| 02/14/2012 | US8114415 Method for producing temperature sensitive influenza A viruses |
| 02/14/2012 | US8114409 Structural proteins of fish pancreatic disease virus and uses thereof |
| 02/14/2012 | US8114407 Tyrosine kinase receptor epitope for use in identifying modulators for prevention and treatment of renal cancer |
| 02/14/2012 | US8114401 Chlamydia trachomatis antigens |
| 02/14/2012 | US8114398 EGLN2 variants and use thereof in preventing or treating thromboembolic disorders and coronary heart disease |
| 02/14/2012 | US8114395 Treatment of viral diseases with recombinant interferon α |
| 02/14/2012 | US8113284 Use of distributed temperature sensors during wellbore treatments |
| 02/14/2012 | CA2597545C Antibody for assay of adamts13 activity and method for assaying the activity |
| 02/14/2012 | CA2463594C Method for unspecific enrichment of bacterial cells |
| 02/14/2012 | CA2423480C Nucleotide sequences mediating male fertility and method of using same |
| 02/14/2012 | CA2402160C Heparinase iii and uses thereof |
| 02/14/2012 | CA2387870C Stabilized proteins |
| 02/14/2012 | CA2356458C Plastid transformation of brassica |
| 02/14/2012 | CA2353789C Chemically modified enzymes with multiple charged variants |
| 02/14/2012 | CA2343135C Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 02/14/2012 | CA2321595C Maltogenic alpha-amylase variants |
| 02/14/2012 | CA2128528C Process for typing of hcv isolates |
| 02/09/2012 | WO2012019157A2 Expression and purification of fusion protein with multiple mbp tags |
| 02/09/2012 | WO2012019103A2 System and apparatus for cell treatment |
| 02/09/2012 | WO2012019086A2 Inhibition of lar phosphatase to enhance therapeutic angiogenesis |
| 02/09/2012 | WO2012018933A2 Reprogramming immortalized b cells |
| 02/09/2012 | WO2012018927A2 Highly multiplexed genotyping using leukoreduced blood samples |
| 02/09/2012 | WO2012018813A2 Modified infectious laryngotracheitis virus (iltv) and uses thereof |
| 02/09/2012 | WO2012018790A2 Dual variable domain immunoglobulins and uses thereof |
| 02/09/2012 | WO2012018764A1 Mice that make binding proteins comprising vl domains |
| 02/09/2012 | WO2012018741A2 Pressurizable cartridge for polymerase chain reactions |
| 02/09/2012 | WO2012018726A1 Method for increasing double-strand break-induced gene targeting |
| 02/09/2012 | WO2012018613A2 Genetic make-up modifies cancer outcome |
| 02/09/2012 | WO2012018257A1 Antisense oligonucleotide directed removal of proteolytic cleavage sites from proteins |
| 02/09/2012 | WO2012018226A2 Mutant microorganism having high production of cadaverine, and preparation method of cadaverine using same |
| 02/09/2012 | WO2012018094A1 Amadoriase having altered substrate specificity |
| 02/09/2012 | WO2012017919A1 Single-stranded nucleic acid molecule having nitrogen-containing alicyclic skeleton |
| 02/09/2012 | WO2012017867A1 Method for testing for psychiatric disorder, test kit for psychiatric disorder, and method for evaluating therapeutic agent and/or prevention agent for psychiatric disorder |
| 02/09/2012 | WO2012017629A1 Nucleic acid analyzer and nucleic acid analysis method |
| 02/09/2012 | WO2012017256A2 Scaffold peptides |